Hence, myeloma-derived exosomal miR-4261 can be delivered to RBCs, and miR-4261 can downregulate the expression of ATP2B4 in target cells, leading to a reduction in PMCA4 protein expression. The gene discussed is ATP2B4; the disease is plasma cell myeloma.